HomeFisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited

New Research Shows Significant Benefits for COPD Patients in the Home Using Fisher & Paykel Healthcare’s myAirvo

4/20/18: The study, a randomised controlled trial undertaken in Denmark, investigated the long-term effects of nasal high flow therapy for COPD patients already being treated with long-term oxygen therapy.